Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Sex Transm Dis. 2021 Dec 1;48(12):991–996. doi: 10.1097/OLQ.0000000000001569

Table 1.

Description of 281 pregnant women recruited from September 2015 until July 2019 and followed for 1 year.

Overall n = 281 Mycoplasma (potentially with CT, NG, or TV) n = 51 No CT, NG, TV or MG n = 230 p
Age in years, mean (SD) 23.3 (3.6) 22.2 (3.2) 23.5 (3.6) 0.017
Gestational age at enrollment (weeks), mean (SD) 23.4 (10.6) 24.1 (10.6) 23.2 (10.7) 0.580
Prior pregnancies, mean (SD) 1.5 (1.7) 1.4 (1.7) 1.5 (1.7) 0.736
History of STI, N (%) 127 (45%) 26 (51%) 101 (44%) 0.446
STI Risk score (range 0 – 10), mean (SD)) 4.0 (1.0) 4.2 (0.9) 3.9 (1.0) 0.043
Race, N (%) < 0.001
 Black 231 (82%) 50 (98%) 181 (79%)
 Other 50 (18%) 1 (2%) 49 (21%)
Education, N (%) 0.216
 High school or less 192 (68%) 34 (67%) 158 (69%)
 Some college 66 (23%) 16 (31%) 50 (22%)
 College degree 13 (5%) 1 (2%) 12 (5%)
 Post graduate 10 (4%) 0 (0%) 10 (4%)
Symptoms, N (%)

 Vaginal discharge 37 (13%) 10 (20%) 27 (12%) 0.202
 Bleeding 5 (2%) 1 (2%) 4 (2%) 1.000
 Dysuria 24 (9%) 5 (10%) 19 (8%) 0.936
 Itching/irritation 5 (2%) 0 (0%) 5 (2%) 0.589
 Dyspareunia 13 (5%) 2 (4%) 11 (5%) 1.000
 Abdominal pain 15 (5%) 4 (8%) 11 (5%) 0.487
 At least one symptom 73 (26%) 18 (35%) 55 (24%) 0.134

SD – standard deviation; STI – sexually transmitted infection; CT – Chlamydia trachomatis; NG - Neisseria gonorrhoeae; TV – Trichomonas vaginalis.